Full Text View
Tabular View
No Study Results Posted
Related Studies
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
This study is currently recruiting participants.
Verified May 2013 by Questcor Pharmaceuticals, Inc.
Study NCT01601236   Information provided by Questcor Pharmaceuticals, Inc.

First Received on May 15, 2012.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
Proteinuria
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Repository Corticotropin Injection
Placebo
Additional drug interventions recognized in this trial
Adrenocorticotropic Hormone
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Questcor Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services